Dose escalation pharmacokinetics and lipid lowering activity of a novel farnesoid X receptor modulator: 16-Dehydropregnenolone.

Indian J Pharmacol · 2012 · PMC3271541 · PMID 22345871

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

administration, ratio of AUC p /AUC m showed an increasing trend.

also in 63,971 other papers

a decreasing trendno p-value reported

Bioavailability exhibited a decreasing trend on increasing the dose from 72 to 150 mg/kg [ Table 1 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.